These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 36271549)
1. Age-dependent association of discharge heart-failure medications with clinical outcomes in a super-aged society. Nakai M; Iwanaga Y; Kanaoka K; Sumita Y; Nishioka Y; Myojin T; Kubo S; Okada K; Soeda T; Noda T; Sakata Y; Imamura T; Saito Y; Yasuda S; Miyamoto Y Biomed Pharmacother; 2022 Nov; 155():113761. PubMed ID: 36271549 [TBL] [Abstract][Full Text] [Related]
2. Heart failure medication after a first hospital admission and risk of heart failure readmission, focus on beta-blockers and renin-angiotensin-aldosterone system medication: A retrospective cohort study in linked databases. Kruik-Kollöffel WJ; van der Palen J; Doggen CJM; van Maaren MC; Kruik HJ; Heintjes EM; Movig KLL; Linssen GCM PLoS One; 2020; 15(12):e0244231. PubMed ID: 33351823 [TBL] [Abstract][Full Text] [Related]
3. Safety, Tolerability and efficacy of Rapid Optimization, helped by NT-proBNP and GDF-15, of Heart Failure therapies (STRONG-HF): rationale and design for a multicentre, randomized, parallel-group study. Kimmoun A; Cotter G; Davison B; Takagi K; Addad F; Celutkiene J; Chioncel O; Solal AC; Diaz R; Damasceno A; Duengen HD; Filippatos G; Goncalvesova E; Merai I; Metra M; Ponikowski P; Privalov D; Sliwa K; Sani MU; Voors AA; Shogenov Z; Mebazaa A Eur J Heart Fail; 2019 Nov; 21(11):1459-1467. PubMed ID: 31423712 [TBL] [Abstract][Full Text] [Related]
4. Adherence and Discontinuation of Optimal Heart Failure Therapies According to Age: A Danish Nationwide Study. Garred CH; Zahir D; Butt JH; Ravn PB; Bruhn J; Gislason GH; Fosbøl EL; Torp-Pedersen C; Petrie MC; McMurray JJV; Køber L; Schou M J Am Heart Assoc; 2022 Oct; 11(19):e026187. PubMed ID: 36172925 [TBL] [Abstract][Full Text] [Related]
5. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488 [TBL] [Abstract][Full Text] [Related]
6. Gap between guidelines and clinical practice in heart failure with reduced ejection fraction: Results from TSOC-HFrEF registry. Chang HY; Wang CC; Wei J; Chang CY; Chuang YC; Huang CL; Chong E; Lin JL; Mar GY; Chan KC; Kuo JY; Wang JH; Chen ZC; Tseng WK; Cherng WJ; Yin WH J Chin Med Assoc; 2017 Dec; 80(12):750-757. PubMed ID: 29033112 [TBL] [Abstract][Full Text] [Related]
7. Effect of Prescribing Patterns of Renin-Angiotensin System Blockers and Beta-Blockers on Prognosis of Heart Failure. Kim HJ; Jo SH; Lee MH; Seo WW; Choi JO; Ryu KH Adv Ther; 2020 Sep; 37(9):3839-3849. PubMed ID: 32676928 [TBL] [Abstract][Full Text] [Related]
8. Discharge treatment with angiotensin-converting enzyme inhibitor/angiotensin receptor blocker after a heart failure hospitalisation is associated with a better prognosis irrespective of left ventricular ejection fraction. Vicent L; Cinca J; Vazquez-García R; Gonzalez-Juanatey JR; Rivera M; Segovia J; Pascual-Figal D; Bover R; Worner F; Delgado-Jiménez J; Fernández-Avilés F; Martínez-Sellés M Intern Med J; 2019 Dec; 49(12):1505-1513. PubMed ID: 30887642 [TBL] [Abstract][Full Text] [Related]
9. Initiation, Continuation, or Withdrawal of Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers and Outcomes in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction. Gilstrap LG; Fonarow GC; Desai AS; Liang L; Matsouaka R; DeVore AD; Smith EE; Heidenreich P; Hernandez AF; Yancy CW; Bhatt DL J Am Heart Assoc; 2017 Feb; 6(2):. PubMed ID: 28189999 [TBL] [Abstract][Full Text] [Related]
10. Pharmacotherapy Treatment Patterns, Outcomes, and Health Resource Utilization Among Patients with Heart Failure with Reduced Ejection Fraction at a U.S. Academic Medical Center. Bress AP; King JB; Brixner D; Kielhorn A; Patel HK; Maya J; Lee VC; Biskupiak J; Munger M Pharmacotherapy; 2016 Feb; 36(2):174-86. PubMed ID: 26841333 [TBL] [Abstract][Full Text] [Related]
11. Heart failure medications prescribed at discharge for patients with left ventricular assist devices. Shreibati JB; Sheng S; Fonarow GC; DeVore AD; Yancy CW; Bhatt DL; Schulte P; Peterson ED; Hernandez A; Heidenreich PA Am Heart J; 2016 Sep; 179():99-106. PubMed ID: 27595684 [TBL] [Abstract][Full Text] [Related]
12. Treatment Patterns, Outcomes, and Persistence to Newly Started Heart Failure Medications in Patients with Worsening Heart Failure: A Cohort Study from the United States and Germany. Michel A; Lecomte C; Ohlmeier C; Raad H; Basedow F; Haeckl D; Beier D; Evers T Am J Cardiovasc Drugs; 2024 May; 24(3):409-418. PubMed ID: 38573461 [TBL] [Abstract][Full Text] [Related]
15. Nurse-coordinated collaborative disease management improves the quality of guideline-recommended heart failure therapy, patient-reported outcomes, and left ventricular remodelling. Güder G; Störk S; Gelbrich G; Brenner S; Deubner N; Morbach C; Wallenborn J; Berliner D; Ertl G; Angermann CE Eur J Heart Fail; 2015 Apr; 17(4):442-52. PubMed ID: 25727879 [TBL] [Abstract][Full Text] [Related]
16. Real-World Analysis of Guideline-Based Therapy After Hospitalization for Heart Failure. Wirtz HS; Sheer R; Honarpour N; Casebeer AW; Simmons JD; Kurtz CE; Pasquale MK; Globe G J Am Heart Assoc; 2020 Aug; 9(16):e015042. PubMed ID: 32805181 [TBL] [Abstract][Full Text] [Related]
17. Renin-Angiotensin System Inhibition and Lower 30-Day All-Cause Readmission in Medicare Beneficiaries with Heart Failure. Sanam K; Bhatia V; Bajaj NS; Gaba S; Morgan CJ; Fonarow GC; Butler J; Deedwania P; Prabhu SD; Wu WC; White M; Love TE; Aronow WS; Fletcher RD; Allman RM; Ahmed A Am J Med; 2016 Oct; 129(10):1067-73. PubMed ID: 27262781 [TBL] [Abstract][Full Text] [Related]
18. Comparative Effectiveness of Dosing of Medical Therapy for Heart Failure: From the CHAMP-HF Registry. Greene SJ; Butler J; Hellkamp AS; Spertus JA; Vaduganathan M; Devore AD; Albert NM; Patterson JH; Thomas L; Williams FB; Hernandez AF; Fonarow GC J Card Fail; 2022 Mar; 28(3):370-384. PubMed ID: 34793971 [TBL] [Abstract][Full Text] [Related]
19. Variation in use and dosing escalation of renin angiotensin system, mineralocorticoid receptor antagonist, angiotensin receptor neprilysin inhibitor and beta-blocker therapies in heart failure and reduced ejection fraction: Association of comorbidities. Albert NM; Tyson RJ; Hill CL; DeVore AD; Spertus JA; Duffy C; Butler J; Patterson JH; Hernandez AF; Williams FB; Thomas L; Fonarow GC Am Heart J; 2021 May; 235():82-96. PubMed ID: 33497697 [TBL] [Abstract][Full Text] [Related]
20. Adherence and persistence to pharmacotherapy in patients with heart failure: a nationwide cohort study, 2014-2020. Ødegaard KM; Lirhus SS; Melberg HO; Hallén J; Halvorsen S ESC Heart Fail; 2023 Feb; 10(1):405-415. PubMed ID: 36266969 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]